Landscapes / Companies

Jazz Pharmaceuticals not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
5 approved
1 in Phase 2
Next date
JZP047, Phase 1 trial completes
Drugs
10
in active trials · 35 in all
Trials
21 active
144 since 2021

Drugs10

DrugHow it worksPartnerStageNext dateDetails
Bispecific HER2-directed antibody
Approved 31 Dec 2026Phase 2 trial completes
—
Approved 1 Aug 2027Phase 4 trial completes
—
Approved 23 Dec 2027Phase 3 trial completes
Alkylating drug
Approved 31 Dec 2027Phase 3 trial completes
Protease activator
Approved Jun 2028Phase 3 trial completes
—
Phase 2 25 Oct 2028Phase 2 trial completes
—
Phase 1 30 Nov 2026soonPhase 1 trial completes
—
Phase 1 27 Feb 2027Phase 1 trial completes
—
Phase 1 30 Nov 2027Phase 1 trial completes
—
Phase 1 1 Apr 2028Phase 1 trial completes

About

No active trial
25 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Jazz Pharmaceuticals

Following is part of Solo: you see every change to Jazz Pharmaceuticals the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in